| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1778802A Crystal form of Peimeiqusai disodium and its preparation |
| 05/31/2006 | CN1778797A Production of N-(pyrrolo[2,3-d] pyrimidine-5-) acyl glusate derivative and intermediate |
| 05/31/2006 | CN1257904C 5-halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053217 Beta-aryl-alpha-oxysubstituted alkylcarboxylic acids; antiobesity and hypocholesterolemic compounds |
| 05/30/2006 | US7053216 Modulators of Rho C activity |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053213 Therapeutic heterocycles |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/30/2006 | CA2208734C Process for preparing 4,6-bis(difluoro-methoxy)pyrimidine derivatives |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/26/2006 | WO2006055561A2 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 05/26/2006 | CA2587427A1 Kinase inhibitors |
| 05/26/2006 | CA2580150A1 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 05/25/2006 | US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 05/25/2006 | US20060111378 Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents |
| 05/25/2006 | US20060111377 Heterocyclic derivatives |
| 05/25/2006 | US20060111376 2,4-Diamino quinazoline and pyridopyrimidine ester derivatives as dihydrofolate reductase inhibitors |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111364 Reversible inhibitors of cysteine proteases S, K, F, L and B; N-[2-(Benzylamino)pyrimidin-4-yl]-N-(cyanomethyl)-L-phenylalaninamide |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors |
| 05/24/2006 | EP1373225B1 Process for coupling amino acids to an antifolate scaffold |
| 05/24/2006 | EP1226129B1 Methods and compositions utilizing quinazolinones |
| 05/24/2006 | DE10347386B4 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 05/24/2006 | CN1777611A Novel process for the preparation of hexacyclic camptothecin |
| 05/24/2006 | CN1777591A Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof |
| 05/24/2006 | CN1777589A Heteroarylcarbamoylbenzene derivative |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775763A Carboxyl acylamide compound and its preparing method and use |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1257153C Novel propargylether derivatives |
| 05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
| 05/23/2006 | US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 05/23/2006 | US7049317 CCR-3 receptor antagonists |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | CA2087591C Pyrimidine-3-oxide used for reducing hair loss; topical compositions used therefor |
| 05/18/2006 | WO2006052913A1 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES |
| 05/18/2006 | WO2006051891A1 Production method of pyrimidine compounds |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051489A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 05/18/2006 | WO2006051290A2 Compounds for treating protein-kinase mediated disorders |
| 05/18/2006 | WO2006050843A1 Aminoquinazolines compounds |
| 05/18/2006 | WO2006014429A3 Cidofovir peptide conjugates as prodrugs |
| 05/18/2006 | WO2006010446A3 Medicinal use of receptor ligands |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106217 Novel compounds and their uses |
| 05/18/2006 | US20060106214 3-isobutyl-8-(6-methoxy-isoquinolin-4-ylmethyl)-1-methyl-3, 7-dihydro-purine-2,6-dione; sexual dysfunction, premature labour, dysmenorrhoea, benign prostatic hyperplasia, bladder outlet obstruction, incontinence, (Prinzmetal) angina, hipotensive agent |
| 05/18/2006 | US20060106033 Pyrazolopyridines and methods of making and using the same |
| 05/18/2006 | US20060105445 Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2586375A1 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
| 05/18/2006 | CA2586105A1 Aminoquinazolines compounds |
| 05/18/2006 | CA2585983A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656354A1 Tetrahydroquinazoline derivatives as cfr antagonists |
| 05/17/2006 | EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656145A1 Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists |
| 05/17/2006 | EP1656144A2 Trp-p8 active compounds and therapeutic treatment methods |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1560878B1 Thermally stabilised pvc compositions |
| 05/17/2006 | EP1516021B1 Printing process using specified azo compounds |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | EP0923941B1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774425A Quinazoline compounds |
| 05/17/2006 | CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 05/17/2006 | CN1256331C Heteropolyacid 5-fluorouracil antineoplastic and method for synthesizing the same |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045649 compounds are suitable, for example, for use as anorectics |
| 05/16/2006 | US7045624 Compounds and their uses |
| 05/16/2006 | US7045538 Neurotransmitter moderator; analgesics; using n-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine |
| 05/16/2006 | US7045530 alzheimer's disease; schizophrenia |
| 05/16/2006 | US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them |
| 05/16/2006 | US7045519 Pyrimidine or pyridine derivatives |
| 05/11/2006 | WO2006049968A1 Pyrimidine and quinoline potentiators of metabotropic glutamate receptors |
| 05/11/2006 | WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor |
| 05/11/2006 | WO2006048336A2 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 05/11/2006 | WO2006048308A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/11/2006 | WO2006048297A1 Process for the production of pyrimidine-5-carboxylates |
| 05/11/2006 | WO2006029385A3 Quinazoline derivatives as metabolically inert antifolate compounds. |
| 05/11/2006 | US20060100430 Process for preparation of 2-alkoxy-6-(trifluoromethyl)pyrimidin-4-ol |
| 05/11/2006 | US20060100250 Biphenyl derivatives and their use as fungicides |